Trials / Completed
CompletedNCT05366634
A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers
A Phase 1, Randomized, Placebo-controlled, Single-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDK-703 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Medikine, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
MDK-703-101 is a single ascending dose study, to determine the safety, tolerability, and PK/PD of MDK-703 in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MDK-703 or Placebo | Injection |
Timeline
- Start date
- 2022-06-30
- Primary completion
- 2022-12-28
- Completion
- 2022-12-28
- First posted
- 2022-05-09
- Last updated
- 2024-05-08
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05366634. Inclusion in this directory is not an endorsement.